| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $4.17M | $4.65M | $10.75M | $13.96M | $15.23M |
| SG&A | $5.78M | $7.04M | $10.69M | $10.87M | $9.30M |
| Operating Income | -$9.95M | -$11.69M | -$21.44M | -$24.82M | -$24.54M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$10.31M | -$11.62M | -$17.19M | -$24.28M | -$24.46M |
| EPS (basic) | -1.1100 | -2.3100 | -0.4000 | -0.6600 | -0.6800 |
| EPS (diluted) | -1.1100 | -2.3100 | -0.4000 | -0.6600 | -0.6800 |
| Shares (diluted) | $9.27M | $5.02M | $43.08M | $36.51M | $36.18M |